Congrats to Congen Pharma for a successful PCHi 2025!
Publish Time:
2025-02-24
From February 19-21, the China International Cosmetics, Personal and Home Care Ingredients Exhibition (PCHi 2025) was successfully held in Guangzhou. Congen Pharma showcased its latest effective ingredients and technological achievements, attracting considerable attention. The three-day exhibition was lively, with numerous product highlights and domestic and international clients gathering to discuss the latest trends.
At the exhibition, Congen Pharma showcased five technology platforms: Hydractiv™ water-soluble enhancement technology, R&Dactiv™ on-demand release technology, Inactiv™ nano-locking technology, Duactiv™ dual-stability technology, and Intide™ intelligent assembly peptide drug delivery technology. These addressed challenges such as the stability and permeability of various ingredients, meeting the diverse R&D and application needs of clients. Among them, the anti-wrinkle peptide and whitening peptide solid active oil, resveratrol Pro, and water-soluble ferulic acid ferulic acid were representative products that became focal points and were highly favored.
The company also presented several star products for anti-wrinkle, whitening, and soothing repair, including copper peptides, dihydroavenanthramide, HPR, Boserin, acetamidine, ergothioneine These products have all obtained Chinese invention patents and, with their unique technological advantages and excellent efficacy, provide brands with more competitive new options.
Innovation at the source builds a brand's moat. Congen Pharma is committed to providing customers with exclusive "core" ingredient solutions. During the exhibition, the company engaged in in-depth exchanges with clients and partners, exploring opportunities in collaborative applications and customized solutions. Many clients expressed high recognition of Congen Pharma's precise empowerment model and looked forward to collaborating to build higher technological barriers and jointly create a new chapter in brand development.
The source of beauty, the excellent choice. Congen Pharma's PCHi 2025 journey concludes successfully. In the future, it will continue to create truly effective and high-quality ingredients for beauty and health, supporting industry progress. Let's meet in Hangzhou in 2026 for the next beauty feast!
Relevant Information
